A Phase 1, Randomized, Placebo-controlled, Multiple Dose Escalation Study to Investigate Safety, Pharmacokinetics, and Pharmacodynamics of SHR0534 in Chinese Type 2 Diabetic Patients
Clinical trial NCT03006159 · COMPLETED
Trial details
- NCT number
- NCT03006159
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-01
- Primary completion
- 2015-12-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.